Update on Biologics for Psoriasis in Clinical Practice

Biologics have impacted the clinical management of moderate to severe psoriasis. This review article highlights new data findings from phase 3 clinical trials (N=8) published between May 2020 and February 2021. Data on the efficacy of US Food and Drug Administration-approved biologics for treating p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cutis 2021-08, Vol.108 (2S), p.15-18
Hauptverfasser:	Ivanic, Mirjana G, Ahn, Grace S, Herndon, Patrick, Wu, Jashin J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal Biological Products - therapeutic use Humans Psoriasis - drug therapy United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!